Form 4: Clorox Executive Nina Barton Files Pre-Planned Stock Disposition for Tax Withholding

Sentiment:

Insider Transaction Report


Clorox EVP Nina Barton reported a pre-planned disposition of 1,610 common shares at $126.57 per share, effective July 22, 2025, to cover tax obligations.

Summary

  • Nina Barton, EVP-Group President-Care & Connected Commerce at Clorox Co. (CLX), filed a Form 4.
  • The filing reports a disposition of 1,610 shares of Clorox Common Stock.
  • The transaction is scheduled for July 22, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
  • The shares were disposed of at a price of $126.57 per share.
  • The transaction code 'F' indicates that the shares were withheld by the issuer to satisfy tax withholding obligations upon the vesting of restricted stock or the exercise of options.
  • Following this transaction, Nina Barton will beneficially own 21,288 shares of Common Stock.
  • The reported beneficial ownership includes 94 shares acquired through a dividend reinvestment feature of the Company's Stock Incentive Plan.

Sentiment

Score: 6

Explanation: The transaction is a routine, pre-planned disposition for tax purposes, which is generally neutral. The executive retains a substantial holding, indicating continued alignment. The future date of the transaction (July 22, 2025) for a filing on July 24, 2025, is unusual for a Form 4, but the 10b5-1(c) checkbox clarifies it as a pre-planned future event, which is a positive for transparency and reduces negative signaling.

Positives

  • The transaction is a routine disposition for tax withholding purposes, indicating a standard compensation event rather than a discretionary sale.
  • The transaction is pre-planned under a Rule 10b5-1(c) plan, which suggests it was set up in advance and not based on recent material non-public information.
  • The executive retains a significant holding of 21,288 shares after the transaction, demonstrating continued alignment with shareholder interests.

Negatives

  • A reduction in direct share ownership, even for tax purposes, technically decreases the executive's direct equity stake.

Future Outlook

The filing indicates a pre-planned future transaction on July 22, 2025, for tax withholding purposes, which is a routine aspect of executive compensation and does not provide specific forward-looking business guidance.

Industry Context

This filing is a routine insider transaction related to executive compensation and does not provide broader industry context or trends. It reflects standard practices for managing equity compensation.

Comparison to Industry Standards

  • This is a standard Form 4 filing for a tax-related disposition of shares, common across publicly traded companies when executives receive equity compensation. There are no specific comparable companies or projects mentioned as this is an individual executive transaction.

Related Party Transactions

  • The transaction involves the disposition of shares to the issuer (Clorox Co.) to satisfy tax withholding obligations, which is a common type of transaction between an executive and their company related to compensation.

Stakeholder Impact

  • Shareholders: The transaction is a routine, non-discretionary sale for tax purposes, which typically has minimal impact on shareholder perception or share price. The executive's continued significant holding aligns interests.
  • Employees: No direct impact on employees is indicated.
  • Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.

Next Steps

  • The reported transaction is scheduled to occur on July 22, 2025.

Key Dates

DateDescription
07/22/2025Date of earliest transaction (disposition of shares for tax withholding).
07/24/2025Date of filing and signature by Attorney-in-Fact.

Recommendation

hold

This Form 4 reports a routine, pre-planned disposition of shares by an executive for tax withholding purposes, which is a common occurrence with equity compensation. It is not a discretionary sale indicating a change in management's outlook on the company. The executive retains a substantial number of shares, maintaining alignment with shareholder interests. Therefore, this specific filing does not provide new information that would warrant a change in investment recommendation.

Keywords

Clorox, CLX, SEC Form 4, Insider Trading, Stock Disposition, Executive Compensation, Tax Withholding, Rule 10b5-1, Nina Barton, Common Stock

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.